• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
  • New
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases

Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases

2-Volume Set

9780323934992
2,212.50 zł
1,880.63 zł Save 331.87 zł Tax included
Lowest price within 30 days before promotion: 1,880.63 zł
Quantity
Teaser
2025-08-08

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
Offering more in-depth coverage of epidemiology, etiology, pathology, microbiology, immunology, and treatment of infectious agents than any other infectious disease resource, Mandell, Douglas, and Bennetts Principles and Practice of Infectious Diseases, 10th Edition, remains your #1 choice for authoritative, comprehensive information in this challenging field. Meticulously updated by a new editorial team led by Drs. Martin J. Blaser, Jeffrey I. Cohen, and Steven M. Holland, this two-volume masterwork brings together the knowledge and expertise of more than 650 contributing authors who are outstanding scholars and experts in their fields. For ID specialists and general practitioners alike, PPID provides a balanced, detailed perspective for any patient you encounter with a complex or difficult-to-treat infectious disease. Encyclopedic in its depth, contents, and referencing, PPID-10 is the one infectious disease book that needs to be on every practitioner’s shelf and in every medical library.

Key Features
  • Organizes content both by individual pathogens and by important clinical syndromes, broadening the context to clearly present relevant, complex clinical information.
  • Contains multiple new chapters on both SARS-CoV-2 and anti-fungal therapy, as well as new chapters on bacteriophages and related agents, infections following traumatic injuries, communication to the public about infectious diseases, and the effects of climate change on infectious diseases.
  • Provides up-to-date coverage of recent advances in the field:: an increasing understanding of the agents, immune responses, and the growing armamentarium of diagnostics (such as nucleic acid amplification and next-generation sequencing); new treatments (such as monoclonal antibodies, new antifungals, antivirals, and phage therapy); and emerging preventive measures (such as new vaccines being developed for RSV), and our relationship with the human microbiome.
  • Features more than 1,500 high-quality, full-color photographs?with many new to this edition.
  • Shares the extensive experience of new editors Drs. Jeffrey I. Cohen and Steven M. Holland, both from Bethesda, MD, as well as a new team of expert associate editors Drs. Yohei Doi, Wendy S. Garrett, Ann R. Falsey, Eleanor Wilson, Kieren Marr, and Edward Mitre—each a leading authority in their field.
  • Includes perspectives from hundreds of leading experts from a truly global community, including authors from Australia, Canada, and countries in Europe, Asia, and South America.
  • Includes regular updates online for the life of the edition.
  • A digital version is included with purchase. The digital version allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish up to 6 weeks following the publication date.

Author Information
Edited by Martin J. Blaser, MD, Henry Rutgers Chair of the Human Microbiome, Professor of Medicine and Microbiology - RWJNS, Director, Center for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, New Jersey, USA; Jeffrey I. Cohen, MD, Bethesda, MD and Steven M. Holland, MD, Bethesda, MD
Product Details
Elsevier
103399
9780323934992
9780323934992

Data sheet

Publication date
2025
Issue number
10
Cover
hard cover
Pages count
4176
Dimensions (mm)
216 x 276
Weight (g)
8250
  • PART I: BASIC PRINCIPLES IN THE DIAGNOSIS AND MANAGEMENT OF INFECTIOUS DISEASES
    Section A: Microbial Pathogens
    1. A Molecular Perspective of Microbial Pathogenicity
    2. The Human Microbiome
    3. Prebiotics, Probiotics, and Synbiotics

    Section B: Host Defense Mechanisms
    4. Innate (General or Nonspecific) Host Defense Mechanisms
    5. Adaptive Immunity: Antibodies and Immunodefiencies
    6. Cell-Mediated Defense Against Infection
    7. Mucosal Immunity
    8. Granulocytic Phagocytes
    9. Complement and Deficiencies
    10. Human Genetics and Infection
    11. Nutrition, Immunity, and Infection
    12. Evaluation of the Patient with Suspected Immunodeficiency

    Section C: Epidemiology of Infectious Disease
    13. Principles of Applied Epidemiology for the Practice of Infectious Diseases
    14. Emerging and Reemerging Infectious Disease Threats
    15. Bioterrorism: An Overview

    Section D: Clinical Microbiology
    16. The Clinician and the Microbiology Laboratory: Test Ordering, Specimen Collection, and Result Interpretation

    Section E: Antiinfective Therapy
    17. Principles of Anti-Infective Therapy
    18. Molecular Mechanisms of Antibiotic Resistance in Bacteria
    19. Pharmacokinetics and Pharmacodynamics of Anti-Infective Agents
    20. Penicillins and ß-Lactamase Inhibitors
    21. Cephalosporins and Cephalosporin/ß-Lactamase Inhibitor Combinations
    22. Carbapenems, Carbapenem/ß-Lactamase Inhibitor Combinations, and Aztreonam
    23. Antibiotic Allergy
    24. Aminoglycosides
    25. Tetracyclines, Tetracycline Derivatives, and Chloramphenicol
    26. Rifamycins
    27. Metronidazole
    28. Macrolides and Clindamycin
    29. Glycopeptides (Vancomycin and Teicoplanin) and Lipoglycopeptides (Telavancin, Oritavancin, and Dalbavancin)
    30. Streptogramins (Quinupristin-Dalfopristin) and Lipopeptides (Daptomycin)
    31. Polymyxins (Polymyxin B and Colistin)
    32. Linezolid,Tedizolid, and Other Oxazolidinones
    33. Sulfonamides and Trimethoprim; Trimethoprim-Sulfamethoxazole
    34. Quinolones
    35. Antibiotics in Advanced Development and Other Agents
    36. Urinary Tract Agents: Nitrofurantoin, Fosfomycin and Methenamine
    37. Topical Antibacterials
    38. Antimycobacterial Agents
    39. Bacteriophage Therapy, Endolysin Therapy and Antimicrobial Peptide Therapy
    40. Antifungal Agents: Polyene Antifungals
    41. Antifungal Drugs: Azole
    42. Antifungal Drugs: Echinocandins and Other Beta-D-glucan Inhibitors
    43. Antifungal Drugs: Flucytosine
    44. Antimalarial Drugs
    45. Drugs for Protozoal Infections Other Than Malaria
    46. Drugs for Helminths
    47. Antiviral Agents: General Principles
    48. Antiviral Drugs for Influenza and Other Respiratory Virus Infections Except for SARS-CoV-2
    49. Antivirals Against Herpesviruses
    50. Antiviral Drugs Against Hepatitis Viruses
    51. Miscellaneous Antivirals Agents (Interferons, Tecovirimat, Imiquimod, Pocapavir)
    52. Immunomodulators
    53. Hyperbaric Oxygen
    54. Antimicrobial Stewardship
    55. Designing and Interpreting Clinical Studies in Infectious Diseases
    56. Outpatient Parenteral Antimicrobial Therapy

    PART II: MAJOR CLINICAL SYNDROMES
    Section A: Fever
    57. Temperature Regulation and the Pathogenesis of Fever
    58. Fever of Unknown Origin
    59. The Acutely Ill Patient with Fever and Rash

    Section B: Upper Respiratory Tract Infections
    60. The Common Cold
    61. Pharyngitis
    62. Acute Laryngitis
    63. Otitis Externa, Otitis Media, and Mastoiditis
    64. Sinusitis
    65. Epiglottitis
    66. Infections of the Oral Cavity, Neck, and Head

    Section C: Pleuropulmonary and Bronchial Infections
    67. Acute Bronchitis
    68. Acute Exacerbations of Chronic Obstructive Pulmonary Disease
    69. Acute Pneumonia
    70. Pleural Effusion and Empyema
    71. Bacterial Lung Abscess
    72. Chronic Pneumonia
    73. Cystic Fibrosis

    Section D: Urinary Tract Infections
    74. Urinary Tract Infections

    Section E: Sepsis
    75. Sepsis and Septic Shock

    Section F: Intraabdominal Infections
    76. Peritonitis and Intraperitoneal Abscesses
    77. Infections of the Liver and Biliary System (Liver Abscess, Cholangitis, Cholecystitis)
    78. Pancreatic Infection
    79. Splenic Abscess
    80. Appendicitis
    81. Diverticulitis and Neutropenic Enterocolitis

    Section G: Cardiovascular Infections
    82. Endocarditis and Intravascular Infections
    83. Prosthetic Valve Endocarditis
    84. Infections of Nonvalvular Cardiovascular Devices
    85. Prophylaxis of Infective Endocarditis
    86. Myocarditis and Pericarditis
    87. Mediastinitis

    Section H: Central Nervous System Infections
    88. Approach to the Patient with Central Nervous System Infection
    89. Acute Meningitis
    90. Chronic Meningitis
    91. Encephalitis
    92. Brain Abscess
    93. Subdural Empyema, Epidural Abscess, and Suppurative Intracranial Thrombophlebitis
    94. Cerebrospinal Fluid Shunt and Drain Infections

    Section I: Skin and Soft Tissue Infections
    95. Cellulitis, Necrotizing Fasciitis, and Subcutaneous Tissue Infections
    96. Myositis and Myonecrosis
    97. Lymphadenitis and Lymphangitis

    Section J: Gastrointestinal Infections and Food Poisoning
    98. Syndromes of Enteric Infection
    99. Esophagitis
    100. Diarrhea with Little or No Fever
    101. Acute Dysentery Syndromes (Diarrhea with Fever)
    102. Typhoid Fever, Paratyphoid Fever, and Typhoidal Fevers
    103. Foodborne Disease (Food Poisoning)
    104. Tropical Sprue and Environmental Enteric Dysfunction

    Section K: Bone and Joint Infections
    105. Infectious Arthritis of Native Joints
    106. Osteomyelitis
    107. Orthopaedic Implant-Associated Infections

    Section L: Diseases of The Reproductive Organs and Sexually Transmitted Diseases
    108. Anogenital Skin and Mucous Membrane Lesions
    109. Urethritis
    110. Vulvovaginitis and Cervicitis
    111. Infections of the Female Pelvis
    112. Prostatitis, Epididymitis, and orchitis

    Section M: Eye Infections
    113. Introduction to Eye Infections
    114. Microbial Conjunctivitis
    115. Microbial Keratitis
    116. Endophthalmitis
    117. Infectious Causes of Uveitis
    118. Periocular Infections

    Section N: Hepatitis
    119. Viral Hepatitis

    Section O: Acquired Immunodeficiency Syndrome
    120. Human Immunodeficiency Viruses
    121. Global Perspectives on Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome
    122. Epidemiology and Prevention of AIDS and HIV Infection, Including Preexposure Prophylaxis and HIV Vaccine Development
    123. Diagnosis of Human Immunodeficiency Virus Infection
    124. The Immunology of HIV-1 Infection, Mechanisms of Viral Persistence, and Prospects for Cure
    125. General Clinical Manifestations of Human Immunodeficiency Virus Infection (Including Acute Retroviral Syndrome and Oral, Cutaneous, Renal, Ocular, Metabolic, and Cardiac Diseases)
    126. Pulmonary Manifestations of Human Immunodeficiency Virus Infection
    127. Gastrointestinal Hepatobiliary and Pancreatic Manifestations of Human Immunodeficiency Virus Infection
    128. Neurologic Diseases Caused By Human Immunodeficiency Virus Type 1 and Opportunistic Infections
    129. Pediatric Human Immunodeficiency Virus Infection
    130. Antiretroviral Therapy for Human Immunodeficiency Virus Infection
    131. Management of Opportunistic Infections Associated with Human Immunodeficiency Virus Infection

    Section P: COVID-19
    132. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Virology
    133. Global perspective and Epidemiology of COVID-19
    134. Immunology and Diagnosis of SARS-CoV-2 and COVID-19
    135. Clinical Manifestations of COVID-19 in Adults and Children
    136. Treatment and Prevention of SARS-CoV-2 (COVID-19)

    Section Q: Miscellaneous Syndromes
    137. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome


    PART III: INFECTIOUS DISEASES AND THEIR ETIOLOGIC AGENTS
    Section A: Viral Diseases
    138. Biology of Viruses and Viral Diseases
    139. Orthopoxviruses: Vaccinia (Smallpox Vaccine), Variola (Smallpox), Mpox, and Cowpox
    140. Other Poxviruses That Infect Humans: (Including Orf Virus) Molluscum Contagiosum, and Yatapoxviruses
    141. Introduction to Herpesviridae
    142. Herpes Simplex Virus
    143. Chickenpox and Herpes Zoster (Varicella-Zoster Virus)
    144. Cytomegalovirus
    145. Epstein-Barr Virus (Infectious Mononucleosis, Epstein-Barr Virus–Associated Malignant Diseases, and Other Diseases)
    146. Human Herpesvirus Types 6 and 7 (Exanthem Subitum)
    147. Kaposi’s Sarcoma–Associated Herpesvirus (Human Herpesvirus Type 8)
    148. Herpes B Virus
    149. Adenoviruses
    150. Papillomaviruses
    151. JC, BK, and Other Polyomaviruses: Progressive Multifocal Leukoencephalopathy, BK Nephropathy, and Merkel Cell Carcinoma
    152. Hepatitis B Virus
    153. Hepatitis D Virus
    154. Human Parvoviruses, Including Parvovirus B19, Human Bocaviruses, and Adeno-Associated Viruses (AAVs)
    155. Orthoreoviruses and Orbiviruses
    156. Coltiviruses (Colorado Tick Fever Virus) and Seadornaviruses
    157. Rotaviruses
    158. Alphaviruses
    159. Rubella Virus (German Measles)
    160. Flaviviruses (Dengue, Yellow Fever, Japanese Encephalitis, West Nile Encephalitis, Usutu Encephalitis, St. Louis Encephalitis, Tick-Borne Encephalitis, Powassan Encephalitis, Kyasanur Forest Disease, Alkhurma Hemorrhagic Fever, Zika)
    161. Hepatitis C
    162. Coronaviruses, Including Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS)
    163. Parainfluenza Viruses
    164. Mumps Virus
    165. Respiratory Syncytial Virus
    166. Human Metapneumovirus
    167. Measles Virus (Rubeola)
    168. Zoonotic Paramyxoviruses: Nipah, Hendra, and Menangle Viruses
    169. Vesicular Stomatitis Virus and Related Vesiculoviruses (Chandipura Virus)
    170. Rabies (Rhabdoviruses)
    171. Marburg and Ebola Virus Hemorrhagic Fevers
    172. Influenza Viruses, Including Avian Influenza and Swine Influenza
    173. Bunyavirus Infections: Hantavirus Syndromes, La Crosse encephalitis, Rift Valley Fever, Crimean-Congo Hemorrhagic Fever, and Others
    174. Lymphocytic Choriomeningitis Virus, Lassa Virus, Lujo Virus, and the South American Hemorrhagic Fever Viruses (Arenaviruses)
    175. Human T-Lymphotropic Virus
    176. Introduction to the Human Enteroviruses and Parechoviruses
    177. Poliovirus
    178. Coxsackieviruses, Echoviruses and Numbered Enteroviruses (EVD-68, EVD-70, EV-A71) )
    179. The Human Parechoviruses
    180. Hepatitis A Virus
    181. Rhinovirus
    182. Noroviruses and Sapoviruses (Caliciviruses)
    183. Astroviruses and Picobirnaviruses
    184. Hepatitis E Virus

    Section B: Prion Diseases
    185. Prions and Prion Diseases of the Central Nervous System (Transmissible Neurodegenerative Diseases)

    Section C: Chlamydial Diseases
    186. Chlamydia Trachomatis (Urogenital Infections and Trachoma)
    187. Psittacosis (Due to Chlamydia psittaci)
    188. Chlamydia Pneumoniae

    Section D: Mycoplasma Diseases
    189. Mycoplasmoides (Mycoplasma) pneumoniae
    190. Genital Mycoplasmas: Mycoplasma Genitalium, Mycoplasma Hominis, Ureaplasma Species

    Section E: Rickettsioses, Ehrlichioses, and Anaplasmoses
    191. Introduction to Rickettsioses, Ehrlichioses, and Anaplasmosis
    192. Rickettsia Rickettsii and Other Spotted Fever Group Rickettsiae (Rocky Mountain Spotted Fever and Other Spotted Fevers)
    193. Coxiella Burnetii (Q Fever)
    194. Rickettsia Prowazekii (Epidemic or Louse-Borne Typhus)
    195. Rickettsia Typhi (Murine Typhus)
    196. Orientia Tsutsugamushi (Scrub Typhus)
    197. Ehrlichia chaffeensis, Anaplasma phagocytophilum, and Other Anaplasmataceae

    Section F: Bacterial Diseases
    198. Introduction to Bacteria and Bacterial Diseases

    Sub-Section I. Infections due to Gram-Positive Bacteria
    199. Staphylococcus Aureus
    200. Staphylococcus Epidermidis and Other Coagulase-Negative Staphylococci
    201. Classification of Streptococci
    202. Streptococcus Pyogenes (Group A streptococcus)
    203. Nonsuppurative Poststreptococcal Sequelae: Rheumatic Fever and Glomerulonephritis
    204. Streptococcus Pneumoniae
    205. Enterococcus Species, Streptococcus Gallolyticus Group and Leuconostoc Species
    206. Streptococcus Agalactiae (Group B Streptococcus)
    207. Viridans Streptococci, Nutritionally Variant Streptococci, and Groups C and G Streptococci
    208. Streptococcus Anginosus Group
    209. Corynebacterium Diphtheriae (Diphtheria)
    210. Other Coryneform Bacteria and Rhodococci
    211. Listeria Monocytogenes
    212. Bacillus Anthracis (Anthrax)
    213. Bacillus Species and Related Genera Other Than Bacillus Anthracis
    214. Erysipelothrix Rhusiopathiae
    215. Whipple Disease

    Sub-Section II. Infections due to Gram-Negative Bacteria
    216. Neisseria Meningitidis
    217. Neisseria Gonorrhoeae (Gonorrhea)
    218. Moraxella Catarrhalis, Kingella, and Other Gram-Negative Cocci
    219. Vibrio Cholerae
    220. Other Pathogenic Vibrios
    221. Campylobacter Jejuni and Related Species
    222. Helicobacter Pylori and Other Gastric Helicobacter Species
    223. Enterobacterales (Enterobacteriaceae)
    224. P. Aeruginosa and Other Pseudomonas Species
    225. Stenotrophomonas Maltophilia and Burkholderia Cepacia Complex
    226. Burkholderia Pseudomallei and Burkholderia Mallei: Melioidosis and Glanders
    227. Acinetobacter Species
    228. Salmonella Species
    229. Bacillary Dysentery: Shigella and Enteroinvasive Escherichia coli
    230. Haemophilus Species, Including H. Influenzae and H. ducreyi
    231. Brucellosis (Brucella Species)
    232. Francisella Tularensis (Tularemia)
    233. Pasteurella Species
    234. Plague (Yersinis Pestis)
    235. Yersinia Enterocolitica and Yersinia Pseudotuberculosis
    236. Bordetella Pertussis
    237. Rat-Bite Fever: Streptobacillus Moniliformis and Spirillum Minus
    238. Legionnaires’ Disease and Pontiac Fever
    239. Capnocytophaga Species
    240. Bartonella, Including Cat-Scratch Disease
    241. Klebsiella Granulomatis (Donovanosis, Granuloma Inguinale)
    242. Other Gram-Negative and Gram-Variable Bacilli

    Sub-Section III. Infections due to Spirochetal Bacteria
    243. Syphilis (Treponema Pallidum)
    244. Endemic Treponematoses
    245. Leptospira Species (Leptospirosis)
    246. Relapsing Fevers Due to Borrelia Species
    247. Lyme Disease (Lyme Borreliosis) Due to Borrelia Burgdorferi

    Sub-Section IV. Infections due to Anaerobic Bacteria
    248. Anaerobic Infections: General Concepts
    249. Clostridioides (Clostridium) difficile Infection
    250. Tetanus (Clostridium Tetani)
    251. Botulism (Clostridium Botulinum)
    252. Diseases Caused by Clostridium
    253. Bacteroides, Prevotella, Porphyromonas, and Fusobacterium Species (And Other Medically Important Anaerobic Gram-Negative Bacilli)
    254. Anaerobic Cocci and Anaerobic Gram-Positive Nonsporulating Bacilli

    Sub-Section V. Infections due to Acid-Fast Organisms
    255. Mycobacterium Tuberculosis
    256. Leprosy (Mycobacterium Leprae)
    257. Mycobacterium Avium Complex
    258. Infections Caused by Nontuberculous Mycobacteria Other Than Mycobacterium Avium Complex
    259. Nocardia Species
    260. Agents of Actinomycosis

    Section G: Mycoses
    261. Introduction to Mycoses
    262. Candida Species
    263. Aspergillus Species
    264. Agents of Mucormycosis and Entomophthoramycosis
    265. Sporothrix Schenckii
    266. Chromoblastomycosis
    267. Mycetoma
    268. Cryptococcosis (Cryptococcus Neoformans and Cryptococcus Gattii)
    269. Histoplasma Capsulatum (Histoplasmosis)
    270. Blastomycosis
    271. Coccidioidomycosis (Coccidioides Species)
    272. Dermatophytosis (Ringworm) and Other Superficial Mycoses
    273. Paracoccidioidomycosis
    274. Uncommon Fungi and Related Species
    275. Pneumocystis Species
    276. Microsporidiosis

    Section H: Protozoal Diseases
    277. Introduction to Protozoal Diseases
    278. Entamoeba Species, Including Amebic Colitis and Liver Abscess
    279. Free-Living Amebae
    280. Malaria (Plasmodium Species)
    281. Leishmania Species: Visceral, Cutaneous, and Mucosal
    282. Trypanosoma Species (American Trypanosomiasis, Chagas Disease): Biology of Trypanosomes
    283. Agents of African Trypanosomiasis (Sleeping Sickness)
    284. Toxoplasma Gondii
    285. Giardia Lamblia
    286. Trichomonas Vaginalis
    287. Babesia Species
    288. Cryptosporidiosis (Cryptosporidium Species)
    289. Cyclospora Cayetanensis, Isospora Belli, Sarcocystis Species, Balantidium Coli, and Blastocystis Species

    Section I: Diseases Due to Toxic Algae
    290. Human Illness Associated With Cyanobacteria and Harmful Algal Blooms, Including Fish and Shellfish Poisoning Syndromes

    Section J: Diseases Due to Helminths
    291. Introduction to Helminth Infections
    292. Intestinal Nematodes (Roundworms)
    293. Tissue Nematodes, Including Trichinellosis, Dracunculiasis, and the Filariases
    294. Trematodes (Schistosomes and Liver, Intestinal and Lung Flukes)
    295. Tapeworms (Cestodes)
    296. Visceral Larva Migrans and Other Uncommon Helminth Infections

    Section K: Ectoparasitic Diseases
    297. Introduction to Ectoparasitic Diseases
    298. Lice (Pediculosis)
    299. Scabies
    300. Myiasis and Tungiasis
    301. Mites, Including Chiggers

    Section L: Diseases of Unknown Etiology
    302. Ticks, Including Tick Paralysis
    303. Kawasaki Disease

    PART IV: SPECIAL PROBLEMS
    Section A: Nosocomial Infections
    304. Infection Prevention and Control in the Healthcare Setting
    305. Disinfection, Sterilization, and Hospital Waste
    306. Infections Caused by Percutaneous Intravascular Devices
    307. Nosocomial Pneumonia
    308. Catheter-Associated Urinary Tract Infection (CAUTI) and Catheter-Associated Asymptomatic Bacteriuria (CA-ASB)
    309. Transfusion- and Transplantation-Transmitted Infections

    Section B: Infections in Special Hosts
    310. Infections in the Immunocompromised Host: General Principles
    311. Prophylaxis and Empirical Therapy of Infection in Cancer Patients
    312. Infections in Recipients of Hematopoietic Cell Transplantation +CAR-Tcell infections
    313. Infections in Solid organ Transplant Recipients
    314. Infections in Older Adults
    315. Infections in Asplenic Patients
    316. Infections in Persons Who Inject Drugs

    Section C: Surgical- and Trauma-Related Infections
    317. Surgical Site Infections and Antimicrobial Prophylaxis
    318. Burns
    319. Infections Following Traumatic Injuries
    320. Bites

    Section D: Immunization
    321. Principles of immunization and public health
    322. Immunizations for Specific Infections

    Section E: Protection of Travelers
    323. Protection of Travelers
    324. Infections in Returning Travelers

    Section F: Emerging Issues in Infectious Diseases
    325. Zoonoses
    326. Communicating about Infectious Diseases to the Public
    327. Basic Principles in Climate Change and Infectious Diseases
Comments (0)